Leisure Acquisition and Ensysce Biosciences will host an investor conference call today at 11 a.m. EST regarding their proposed business combination. The deal calls for Ensysce to merge into a wholly-owned subsidiary of Leisure in a transaction that reflects a pro forma enterprise valuation for Ensysce of approximately $207 million, based on a stock price for Leisure of $10 per share.
Interested parties may listen to the call via telephone by dialing 1-877-870-4263, or for international callers, 1-412-317-0790. An audio replay will be available shortly after the call at www.leisureacq.com.
An investor presentation will be made available at www.leisureacq.com prior to the call. Read more.
